![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TTC22 |
Gene summary for TTC22 |
![]() |
Gene information | Species | Human | Gene symbol | TTC22 | Gene ID | 55001 |
Gene name | tetratricopeptide repeat domain 22 | |
Gene Alias | TTC22 | |
Cytomap | 1p32.3 | |
Gene Type | protein-coding | GO ID | NA | UniProtAcc | Q5TAA0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55001 | TTC22 | HTA11_2487_2000001011 | Human | Colorectum | SER | 9.84e-06 | 5.08e-01 | -0.1808 |
55001 | TTC22 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.85e-10 | 4.44e-01 | -0.1954 |
55001 | TTC22 | HTA11_411_2000001011 | Human | Colorectum | SER | 1.17e-03 | 9.62e-01 | -0.2602 |
55001 | TTC22 | HTA11_866_2000001011 | Human | Colorectum | AD | 2.24e-02 | 1.75e-01 | -0.1001 |
55001 | TTC22 | HTA11_5212_2000001011 | Human | Colorectum | AD | 9.38e-03 | 3.90e-01 | -0.2061 |
55001 | TTC22 | HTA11_546_2000001011 | Human | Colorectum | AD | 6.85e-04 | 2.68e-01 | -0.0842 |
55001 | TTC22 | A002-C-116 | Human | Colorectum | FAP | 3.85e-03 | -8.90e-02 | -0.0452 |
55001 | TTC22 | LZE22T | Human | Esophagus | ESCC | 2.76e-03 | 3.19e-01 | 0.068 |
55001 | TTC22 | LZE24T | Human | Esophagus | ESCC | 8.82e-07 | 1.95e-01 | 0.0596 |
55001 | TTC22 | P1T-E | Human | Esophagus | ESCC | 6.66e-05 | 4.47e-01 | 0.0875 |
55001 | TTC22 | P2T-E | Human | Esophagus | ESCC | 1.16e-09 | 1.55e-01 | 0.1177 |
55001 | TTC22 | P4T-E | Human | Esophagus | ESCC | 2.89e-03 | 9.87e-02 | 0.1323 |
55001 | TTC22 | P5T-E | Human | Esophagus | ESCC | 8.67e-10 | 1.33e-01 | 0.1327 |
55001 | TTC22 | P8T-E | Human | Esophagus | ESCC | 4.00e-13 | 1.43e-01 | 0.0889 |
55001 | TTC22 | P9T-E | Human | Esophagus | ESCC | 4.17e-02 | 8.42e-02 | 0.1131 |
55001 | TTC22 | P10T-E | Human | Esophagus | ESCC | 1.63e-10 | 1.15e-01 | 0.116 |
55001 | TTC22 | P12T-E | Human | Esophagus | ESCC | 8.32e-12 | 1.77e-01 | 0.1122 |
55001 | TTC22 | P15T-E | Human | Esophagus | ESCC | 1.97e-16 | 3.39e-01 | 0.1149 |
55001 | TTC22 | P16T-E | Human | Esophagus | ESCC | 2.83e-06 | 8.95e-02 | 0.1153 |
55001 | TTC22 | P20T-E | Human | Esophagus | ESCC | 1.74e-21 | 5.26e-01 | 0.1124 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TTC22 | SNV | Missense_Mutation | novel | c.1147N>G | p.Phe383Val | p.F383V | Q5TAA0 | protein_coding | tolerated(0.1) | benign(0) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
TTC22 | SNV | Missense_Mutation | novel | c.814N>T | p.Asp272Tyr | p.D272Y | Q5TAA0 | protein_coding | deleterious(0) | probably_damaging(0.92) | TCGA-DD-AADF-01 | Liver | liver hepatocellular carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TTC22 | SNV | Missense_Mutation | novel | c.657N>T | p.Glu219Asp | p.E219D | Q5TAA0 | protein_coding | tolerated(0.45) | benign(0) | TCGA-05-4397-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
TTC22 | SNV | Missense_Mutation | c.296N>G | p.Asn99Ser | p.N99S | Q5TAA0 | protein_coding | deleterious(0.04) | probably_damaging(0.987) | TCGA-55-1592-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
TTC22 | SNV | Missense_Mutation | novel | c.25N>A | p.Asp9Asn | p.D9N | Q5TAA0 | protein_coding | deleterious(0.02) | benign(0.037) | TCGA-CN-6020-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
TTC22 | SNV | Missense_Mutation | c.835N>T | p.Asp279Tyr | p.D279Y | Q5TAA0 | protein_coding | deleterious(0) | possibly_damaging(0.479) | TCGA-D6-6516-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
TTC22 | SNV | Missense_Mutation | novel | c.723N>C | p.Glu241Asp | p.E241D | Q5TAA0 | protein_coding | tolerated(0.43) | benign(0.007) | TCGA-T2-A6X2-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
TTC22 | SNV | Missense_Mutation | c.181N>A | p.Ala61Thr | p.A61T | Q5TAA0 | protein_coding | tolerated(1) | benign(0.003) | TCGA-CD-8536-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Chemotherapy | epirubicin | CR | |
TTC22 | SNV | Missense_Mutation | novel | c.65C>A | p.Pro22Gln | p.P22Q | Q5TAA0 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-EM-A2CK-01 | Thyroid | thyroid carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |